CD8A and COVID-19: In this study, peripheral blood samples were collected from COVID-19 patients to compare and identify cellular immune responses, including CD3+, CD8+, and CD4+ T cell production, between different COVID-19 patient groups classified as having moderate infection, hospitalized (under medication), and recovered from COVID-19.